TKPHF
Takeda Pharmaceutical Company
Exchange: PINK
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, sale, and import/export of pharmaceutical drugs worldwide. It provides products in various therapeutic areas, including cardiovascular and metabolic, respiratory and immunology, oncology, central nervous system, general medicine, vaccines, and consumer healthcare drugs and quasi-drugs. The company has strategic partnership with BioMotiv, LLC; and a collaboration agreement with Mersana Therapeutics Inc. and Queen Mary University of London. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.
Current Price
$32.26
+0.00%Profile
Valuation (TTM)
Market Cap—
P/E—
EV—
P/B—
Shares Out—
P/Sales—
Revenue—
EV/EBITDA—
Takeda Pharmaceutical Company (TKPHF) Stock Analysis
Market Cap—
Current Price$32.26
P/E Ratio—
Forward P/E—
PEG Ratio—
EPS—
Book Value—
P/B Ratio—
TKPHF Financial Charts
TKPHF 52-Week Range
$25.71
$39.20
50-Day MA: $34.01200-Day MA: $31.09
Did you know?
Price sits at 49% of its 52-week range.
Takeda Pharmaceutical Company (TKPHF) Financial Summary
Takeda Pharmaceutical Company (TKPHF) is a diversified company, listed on PINK. The stock currently trades at $32.26.
..
TKPHF Key Financial Metrics
| Metric | Value |
|---|
About Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, sale, and import/export of pharmaceutical drugs worldwide. It provides products in various therapeutic areas, including cardiovascular and metabolic, respiratory and immunology, oncology, central nervous system, general medicine, vaccines, and consumer healthcare drugs and quasi-drugs. The company has strategic partnership with BioMotiv, LLC; and a collaboration agreement with Mersana Therapeutics Inc. and Queen Mary University of London. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.